3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Sands China Ltd., Las Vegas Sands' majority-owned subsidiary, said it intends to offer USD-denominated senior unsecured notes, with terms to be set at pricing. The filing says no binding agreement exists yet and the offering may or may not happen, so shareholders have no confirmed deal or financial effect to assess.
Sands China intends to offer USD-denominated senior unsecured notes; principal amounts, interest rates and other terms will be determined at pricing.
Planned uses include redeeming in full its US$700 million 2.300% senior notes due 2027, repaying the balance on its 2024 SCL Revolving Facility, and general corporate purposes.
As of October 26, 2026, no binding agreement existed, and Sands China has an eligibility letter from the Hong Kong Stock Exchange for a proposed listing of the notes.
Better Home & Finance Holding Co appointed Linda Yaccarino as an independent director effective October 20, 2026, and director Paula Tuffin resigned from the board effective immediately, as of October 22, 2026. Tuffin remains General Counsel, Chief Compliance Officer and Secretary, and the filing reports no disagreement behind her resignation. The changes alter board composition but the filing reports no financial results or operational impact.
Linda Yaccarino appointed to the Board effective October 20, 2026, with a term expiring at the 2027 annual meeting
Yaccarino will receive annual compensation of $175,000 in restricted stock
Paula Tuffin resigned from the Board effective immediately, notifying the Board on October 22, 2026
Tuffin will continue as General Counsel, Chief Compliance Officer and Secretary
Bain Capital Specialty Finance, Inc. (BCSF) said it will release its results for the quarter ended September 30, 2026 after market close on November 9, 2026, and host a conference call on November 10, 2026. The filing furnishes a press release that schedules the release and call and does not disclose any financial results, so it gives shareholders a date but no performance figures.
Quarter ended September 30, 2026 results to be released Monday, November 9, 2026 after market close
Conference call scheduled for Tuesday, November 10, 2026 at 10:00 a.m. Eastern Time
Archived replay available through November 24, 2026
Amgen's board appointed David W. Gibbs as a director effective October 26, 2026. He will sit on the Audit Committee and the Compensation and Management Development Committee, and the board will have 13 directors, 12 of them independent. The filing describes a board seat, not a change in management, and discloses no financial results.
Gibbs was CEO of Yum! Brands from 2020 to September 2025 and has advised the company since October 2025.
He also serves on the boards of Under Armour, Inc. (since 2021) and PepsiCo, Inc. (since 2026).
Non-employee director pay includes a $115,000 annual cash retainer and a $220,000 annual equity grant, prorated for 2026.
The board will have 13 directors, 12 of whom are independent.
Perpetua Resources amended warrants covering 1,607,802 common shares, extending each expiry by up to six months. Its subsidiary also entered a cost-share Tungsten OTIA with the U.S. Army to evaluate tungsten concentrate production at the Stibnite Mining District, with a total estimated cost of up to about $85 million and a cost-share of up to $45 million. The filing gives shareholders a clearer view of potential dilution timing and a new federal-funded exploration program, though the filing notes later phases depend on future approvals and results.
Warrants for 1,607,802 common shares at $31.46 and $38.93 had original expiries of October 28, December 1 and December 23, 2026; each is extended by up to six months.
Tungsten OTIA total estimated cost is up to about $85 million, with cost-share of up to $45 million over a period ending October 19, 2029.
Subsidiary Perpetua Resources Idaho will match the U.S. Army's $40 million contribution; the initial 18-month phase is expected to cost about $18 million, shared equally.
Faraday Future (FFAI) said its robotics business and related assets were transferred to FF EAI Robotics Ecosystem (Nasdaq: FFR) after an October 23, 2026 closing, with FFR issuing common and non-voting convertible preferred shares to Smart Technology Holdings, a FFAI subsidiary, as consideration. The filing gives FFR's standalone guidance of about 2,000 robots for 2026 and five-year projections, which the company says are not guarantees and do not represent FFR's consolidated 2026 results. For FFAI shareholders, the filing describes a shift from EV manufacturing toward robotaxi and robotics operations, but it does not report FFAI's own financial results or the value of its FFR stake.
Transaction closed October 23, 2026; FFR received the robotics business and related assets
FFR issued common and non-voting convertible preferred shares to Smart Technology Holdings Ltd., a FFAI subsidiary
FFR expects October 2026 sales and shipments above 300 robots and cumulative sales above 1,100 robots by end of October
FFR projects 2027 revenue of about $45.2 million and cumulative five-year revenue of about $1.98 billion
The NYSE has begun proceedings to delist Eve Holding's public warrants, ticker EVEXW, and suspended trading in them because of an abnormally low selling price. The filing says the common stock, ticker EVEX, is not affected and continues to trade on the NYSE.
NYSE notified the company on October 21, 2026 and the company announced it publicly on October 22, 2026.
Warrants (EVEXW) are suspended from trading and the NYSE will apply to the SEC to delist them once procedures are complete.
Each warrant is exercisable for one share of common stock at $11.50 per share.
Common stock (EVEX) continues to trade on the NYSE, subject to the company's other listing requirements.
The trust that holds Wal-Mart Stores, Inc. 7.55% Notes due 2030 made its scheduled October 15, 2026 distribution to certificateholders. The distribution was entirely interest, with no principal paid and no missed interest, and the filing is a routine administrative notice.
Swap counterparty payment received and distributed as interest: $53,014.26
Total distribution per $25 certificate: $0.09700333, all interest, no principal
Underlying Wal-Mart 7.55% Notes due February 15, 2030 held: $13,663,000 aggregate liquidation amount
546,520 certificates outstanding; no aggregate interest due and unpaid
The trust for STRATS certificates Series 2005-6, which hold Dominion Resources Series B 5.95% Senior Notes due 2035, made its scheduled October 15, 2026 distribution to holders, all of it as interest. The filing reports no principal paid, no unpaid interest and no fees charged to the trust, so it is a routine periodic payment for certificate holders.
Total distribution of $0.10639315 per $25 certificate, all interest; principal paid was $0.000000
Swap counterparty amount received on October 15, 2026 was $40,535.79
Trust holds $9,525,000 aggregate liquidation amount of Dominion Resources Series B 5.95% Senior Notes due June 15, 2035
381,000 certificates outstanding, representing $9,525,000 certificate principal balance
Luxfer Holdings PLC filed supplemental disclosures to its definitive proxy statement for its proposed $17.37-per-share cash sale to Double Eagle Acquisition Buyer, a Wynnchurch Capital-backed entity. The company said the disclosures respond to two New York lawsuits and demand letters alleging the proxy omitted material information, and that they do not change the consideration or the November 4, 2026 meeting timing. Shareholders are still asked to vote on the transaction, and the board continues to recommend voting FOR.
Proposed cash consideration is $17.37 per ordinary share; shareholder meetings are set for November 4, 2026.
Two lawsuits, Johnson v. Luxfer Holdings PLC and Thompson v. Luxfer Holdings PLC, were filed in the Supreme Court of the State of New York.
Supplemental disclosures cover standstill provisions, Deutsche Bank's discounted cash flow analysis (implied value $15.05 to $20.80 per share), and precedent transaction multiples.
The company says the allegations are without merit and that it denies all allegations in the actions.
On October 26, 2026, West Pharmaceutical Services entered a new credit agreement with Bank of America as administrative agent. It includes a $750 million revolving facility and a $200 million term loan advanced on the effective date, and the company used the borrowings to repay $130.0 million outstanding under its 2019 credit agreement, which it terminated with no early termination penalties. The filing reports no change to earnings or guidance, but it sets new debt terms, including a maximum net leverage ratio of 3.50 to 1.0.
New credit agreement provides a $750 million revolving facility and a $200 million term loan, with a five-year term from October 26, 2026.
$130.0 million outstanding under the 2019 credit agreement was repaid in full on October 26, 2026, with no early termination penalties.
Borrowings are unsecured; the net leverage covenant caps the ratio at 3.50 to 1.0, or 4.00 to 1.0 during material acquisition periods.
Term loan quarterly amortization starts March 31, 2028, at $1.25 million to $2.5 million per quarter, with the balance due at maturity.
Green Brick Partners, Inc. appointed Jed Dolson, its Co-Chief Executive Officer, to its Board of Directors effective immediately, with the appointment made October 22, 2026. The Board was expanded to seven directors at the same time, and Mr. Dolson will stand for re-election at the 2027 Annual Meeting of Stockholders.
Board appointed Jed Dolson, Co-Chief Executive Officer, as a director on October 22, 2026, effective immediately
Board size increased to seven directors concurrent with the appointment
Mr. Dolson's term expires at the 2027 Annual Meeting of Stockholders, when he will stand for re-election
Filing states no arrangements or reportable related-party transactions involving Mr. Dolson
Cycurion's board determined that director Peter R. Ginsberg no longer meets independence requirements for three board committees because of legal work his law firm performed for the company in 2026. Ginsberg stepped down from those committees effective October 20, 2026, but remains a director, and J. Derek Penn was appointed to the board and to the Audit, Compensation, and Nominating and Corporate Governance committees.
Peter R. Ginsberg stepped down from the Audit, Compensation, and Nominating and Corporate Governance committees effective October 20, 2026, and remains a director.
The company cited payments made during 2026 to Ginsberg's law firm as the reason he no longer met independence requirements, which it attributes to an administrative oversight.
J. Derek Penn was appointed to fill a board vacancy effective October 20, 2026, and joined the three committees the same day.
The company says it is implementing enhanced procedures for director independence reviews and related-party transaction monitoring.
Equillium said on October 26, 2026 that it dosed the first subject in its Phase 1 trial of EQ504 in Australia, which triggered the Milestone Closing of its August 2025 private placement. The company sold 14,957,260 shares at $0.57 and 20,130,457 pre-funded warrants at $0.5669 for gross proceeds of about $20.0 million before fees. The sale adds to the share count, and the company must file resale registration statements within 30 days, with cash penalties for registration failures.
Milestone Closing on October 26, 2026: 14,957,260 shares at $0.57 and 20,130,457 pre-funded warrants at $0.5669 each.
Gross proceeds of about $20.0 million before fees; total equity private placement proceeds of about $50 million.
Investors waived the $2.50 weighted average price threshold on October 26, 2026.
Registration statements for resale must be filed within 30 days of the Milestone Closing, with cash penalties for registration failures.
Onconetix, Inc. said its Board approved an additional one-for-ten reverse stock split of its common stock, which will bring the aggregate split ratio under the stockholder-approved authority to one-for-one hundred with a May 21, 2026 split. Shares are expected to begin trading on a split-adjusted basis on Nasdaq on November 6, 2026, under the existing symbol ONCO. The split reduces the share count but does not change any stockholder's percentage ownership, apart from cash paid for fractional shares.
Reverse split of one-for-ten is expected to take effect at 12:01 a.m. Eastern Time on November 6, 2026
Outstanding shares expected to fall from approximately 5.9 million to approximately 589,000
Combined with the May 21, 2026 split, the aggregate ratio is one-for-one hundred; new CUSIP 68237Q500 and symbol ONCO unchanged
No fractional shares will be issued; holders will receive cash in lieu, and authorized shares remain at 250,000,000
New Mountain Finance Corporation's board approved on October 20, 2026 an extension of its stock repurchase program through December 31, 2027, from the original December 31, 2026 expiry. The company says about $70 million of repurchases have been made under the $150 million program so far, and it may buy shares but is not obligated to do so.
Board approved the extension on October 20, 2026; announced in a press release dated October 26, 2026
Program authorizes repurchases of up to $150 million of common stock, now running through December 31, 2027
Approximately $70 million of repurchases made to date under the program
Company says it believes sustained market volatility may leave its stock undervalued from time to time
XBP Global Holdings disclosed that Chairman Par Chadha has told the company he will not seek re-election to the Board at the next annual meeting of stockholders. The company said the decision was not due to any disagreement over its operations, policies or practices, and Chadha will remain chairman and a director until his current term expires or he resigns earlier.
Par Chadha notified the company on October 20, 2026 that he will not stand for re-election as a director.
He will continue as Chairman and director until his current term expires, unless he resigns earlier.
The company stated the decision did not stem from any disagreement on operations, policies or practices.
Rallybio's board declared an estimated $82.7 million special cash distribution, or about $13.56 per share, payable to holders of record as of November 5, 2026, in connection with its planned merger with Avenzo Therapeutics. Payment depends on stockholder approval at the November 4, 2026 annual meeting, and the actual amount may be higher or lower than the estimate. Shareholders buying during the due bill period (November 4 through November 6, 2026) will receive the distribution, while sellers will not.
Estimated cash distribution of $82.7 million, or $13.56 per share, based on 6,378,168 shares and equivalents outstanding as of October 21, 2026
Record Date November 5, 2026; ex-dividend date expected November 6, 2026; distribution scheduled for November 13, 2026
Payment conditioned on Required Company Stockholder Vote at the annual meeting at 10:00 a.m. Eastern Time on November 4, 2026
Merger closing expected on or about November 6, 2026
Standex International named Brenna D. Preisser, president of Brunswick's boat group, as an independent director effective January 1, 2027, succeeding longtime director B. Joanne Edwards, who is retiring. The filing says the change followed a succession planning process and that Edwards' retirement was not due to any disagreement with the company.
Preisser appointed Class I director effective January 1, 2027; Edwards retires from the board effective the same date after serving since 2018
Preisser to join the Compensation Committee and Innovation & Technology Committee; Edwards chairs the Nominating & Corporate Governance Committee
Preisser receives a restricted stock award valued at $150,000 vesting on the third anniversary of the grant date
On October 20, 2026, Soren Acquisition Corp. replaced its chief financial officer and changed three of its board seats, with Joseph Tonnos becoming CFO in place of Jamie Weber, who also resigned as a director. Arghavan Di Rezze remains chief executive officer. The filing reports no financial results, and the compensation for the new directors and CFO has not been determined.
Joseph Tonnos was appointed CFO effective October 20, 2026, succeeding Jamie Weber, who resigned as CFO and director.
Spencer Gerrol and Charles N. Kahn III resigned as directors effective October 20, 2026; Roger Cloutier Jr., Austin Criden and Joseph Tonnos filled the three vacancies.
Compensation for the new directors and CFO has not been determined; each is expected to receive an indirect economic interest in founder shares held by sponsor Soren Holdings LLC.
The company furnished an October 26, 2026 press release announcing the appointments as Exhibit 99.1.
Kinetik subsidiary EagleClaw Midstream Ventures agreed on October 23, 2026 to resolve a previously disclosed dispute with Energy Transfer over when an NGL purchase agreement expires. Under the settlement, both parties confirmed the agreement's final day of term is December 31, 2026. The filing notes that a related litigation over two Energy Transfer agreements, including this one, remains pending adjudication.
Settlement agreed October 23, 2026 between EagleClaw Midstream Ventures and Energy Transfer GC NGL Product Services
ECMV NGL purchase agreement final day of term confirmed as December 31, 2026
The agreement is one of two Energy Transfer agreements subject to previously disclosed litigation, which awaits adjudication
Supernus Pharmaceuticals terminated its uncommitted UBS revolving credit line on October 20, 2026, in connection with its planned business combination with Indivior Pharmaceuticals and a new senior secured credit facility for the combined company. The company reported no outstanding borrowings and no early termination penalties, so the termination itself has no direct financial cost disclosed in the filing.
Terminated UBS Credit Line Agreement dated February 8, 2023, with UBS Bank USA on October 20, 2026
No advances, letters of credit or other borrowings were outstanding at termination
No early termination penalties were incurred; the Bank's security interests in the collateral were released
Termination tied to the pending combination with Indivior Pharmaceuticals under a merger agreement dated August 1, 2026
Columbus McKinnon's Board approved a regular quarterly dividend of $0.07 per common share on October 26, 2026. Shareholders of record on November 6, 2026 will receive the payment on or about November 16, 2026, and the filing notes about 28.9 million common shares outstanding.
Dividend amount: $0.07 per common share, declared October 26, 2026
Record date: close of business November 6, 2026
Payment date: on or about November 16, 2026
Approximately 28.9 million common shares outstanding per the press release
Praetorian Acquisition Corp. announced a leadership transition effective October 20, 2026. Peter Ondishin resigned as Chief Financial Officer and director, and Joseph Tonnos was appointed CFO, while three directors resigned and three new independent directors were appointed. Justin Di Rezze, M.D. continues as Chief Executive Officer, and the compensation arrangements for the new directors and CFO have not been determined.
Nicole Seligman, Erica Dorfman and Alex Elias resigned as directors effective October 20, 2026; they also served on the Audit and Compensation Committees.
Peter Ondishin resigned as Chief Financial Officer and director effective October 20, 2026.
Joseph Tonnos was appointed Chief Financial Officer and a Class II director; Roger L. Cloutier Jr., Jimmy Vaiopoulos and Charles P. Garcia were appointed as directors.
Compensation for the new directors and CFO has not been determined; they will enter the Company's standard director indemnity agreement.
TrueBlue appointed Elizabeth Castro Gulacsy, former CFO of United Parks & Resorts, as an independent director effective October 26, 2026, and she joins the Audit Committee. The appointment was made under a Cooperation Agreement with Eric H. Su and related entities dated April 10, 2026, and it expands the board to ten directors.
Elizabeth Castro Gulacsy appointed to the board effective October 26, 2026; board increased from nine to ten directors
She will serve on the Audit Committee; nine of the ten directors are independent
Appointment made under a Cooperation Agreement with Eric H. Su, EHS Management LLC and EHS Azure Opportunity Fund LP dated April 10, 2026
Prior roles include CFO and Treasurer of United Parks & Resorts and Chief Accounting Officer at Cross Country Healthcare
D.R. Horton appointed Carl E. Reichardt, Jr. as an independent director effective October 22, 2026, expanding the board to nine members, seven of them independent. He receives annual cash fees of $80,000 and equity awards with grant-date values of $235,000 and $250,000, a routine governance change with limited direct financial effect on shareholders.
Carl E. Reichardt, Jr. appointed to the Board effective October 22, 2026; board expands to nine directors, seven independent
Annual cash fees of $80,000, paid in quarterly installments of $20,000
Annual RSU award with $235,000 grant-date value, plus one-time new director RSU award of $250,000
Board will consider committee appointments after the January 14, 2027 Annual Meeting of Stockholders
Applied Materials entered into an accelerated share purchase agreement on October 26, 2026, to buy more shares of BE Semiconductor Industries (Besi). Including its existing holding, Applied would own about 20% of Besi's outstanding shares. Delivery of the shares depends on the expiration or termination of the HSR Act waiting period, and the filing gives no purchase price or financial impact.
Post-purchase ownership would be about 20% of Besi's outstanding common stock, including Applied's existing shares.
Applied first invested in Besi in April 2025 and says the stake is long term.
Share delivery is subject to the expiration or termination of the HSR Act waiting period.
Applied says it has no current intention to go above 20% and does not intend to seek a Besi board seat.
Health In Tech appointed Sanjay Shrestha as Chief Executive Officer effective October 20, 2026, succeeding founder Tim Johnson, who became Executive Chairman on the same date. The filing sets out Shrestha's employment terms and restricted stock awards, and part of the equity grant depends on stockholder approval of a plan amendment.
Shrestha, age 52, previously served as a director from April 2025 until his resignation in August 2026.
Base salary is $500,000, increasing to at least $700,000 upon the Company raising at least $10,000,000.
Sign-On Award of 2,000,000 Class A shares; Market Capitalization Awards total 4,500,000 shares.
MC-2, MC-3 and MC-4 tranches (2,500,000 shares) depend on stockholder approval at the November 10, 2026 annual meeting.
Northpointe Bancshares' Board approved a stock repurchase program of up to $30 million of its outstanding common stock, running from October 22, 2026 to October 22, 2027. The filing says repurchases may be made in the open market or in privately negotiated transactions, and the program can be changed or ended at any time, so shareholders would see the effect only as shares are actually bought.
Program authorizes up to $30 million of outstanding common stock repurchases
Program period runs from October 22, 2026 through October 22, 2027
Repurchases may occur in the open market or in privately negotiated deals, and may use Rule 10b5-1 plans
Chairman and CEO Chuck Williams cited confidence in the business model and strong capital position
Fidus Investment Corporation closed an exchange offer on October 20, 2026, swapping $120.0 million of privately issued 6.625% notes due 2029 for registered notes with the same principal and terms. The filing confirms the notes are unsecured obligations that mature June 1, 2029, and the holders' principal amount is unchanged, so the exchange itself does not add new debt.
Exchange offer closed October 20, 2026; holders now hold the same $120.0 million principal in registered Exchange Notes
Notes bear 6.625% annual interest, paid semi-annually on June 1 and December 1, starting December 1, 2026, and mature June 1, 2029
Notes are unsecured and rank pari passu with existing unsecured debt, including the 6.750% notes due 2030; effectively and structurally subordinated to secured debt and subsidiary obligations
Seres Therapeutics said Chief Financial Officer Marella Thorell resigned from her executive vice president and CFO roles on October 22, 2026, effective November 15, 2026. The company said she is expected to provide advisory services after that date to support an orderly transition, on terms still to be agreed.
Marella Thorell resigned as EVP and Chief Financial Officer on October 22, 2026
Resignation takes effect November 15, 2026
Thorell is expected to provide advisory services to support an orderly transition, terms not yet agreed
Unitil's subsidiary Maine Natural Gas issued $40 million of 5.95% senior unsecured notes due October 21, 2031, and the parent repaid all outstanding amounts under its Bank of Nova Scotia credit agreement on October 22, 2026. The notes are intended to refinance existing company debt and for general corporate purposes, and the repayment of the credit facility is a financing refinancing step with no reported change in earnings or guidance.
Maine Natural Gas Corporation sold $40,000,000 of 5.95% Senior Unsecured Notes due October 21, 2031, under a Note Purchase Agreement dated October 21, 2026.
Unitil repaid all outstanding amounts under its Amended and Restated Credit Agreement with The Bank of Nova Scotia on October 22, 2026, without premium or penalty.
The credit agreement had a borrowing limit of $86.0 million for tranche A and $50.0 million for tranche B, and the company may not reborrow repaid amounts.
Net proceeds are planned for refinancing existing debt of the company and/or general corporate purposes.
Nasdaq elected Börje Ekholm, former President and CEO of Ericsson, to its Board of Directors effective November 1, 2026, where he will serve on the Audit & Risk Committee. Director Holden Spaht will leave the Board and all committees effective December 31, 2026, and the company said his decision was not due to any disagreement with Nasdaq. The changes are board composition updates that do not alter reported financial results.
Börje Ekholm elected to the Board on October 21, 2026, effective November 1, 2026, and named to the Audit & Risk Committee
Ekholm was President and CEO of Ericsson from January 2017 to September 2026 and previously chaired Nasdaq's Board from May 2012 to December 2016
Holden Spaht notified Nasdaq on October 22, 2026 of his resignation from the Board, effective December 31, 2026
A non-officer immediate family member of Ekholm is employed by Nasdaq; the Audit & Risk Committee reviewed and ratified that compensation
Walter H. Wilkinson Jr. resigned from Gladstone Investment's board of directors effective immediately, after notifying the company on October 22, 2026. The board elected George "Chip" Stelljes, III to succeed him as Lead Independent Director effective October 26, 2026, and reduced the board to seven directors on the same date.
Walter H. Wilkinson Jr. resigned from the board effective immediately; he had served as a director since 2014 and as Lead Independent Director since 2024.
George "Chip" Stelljes, III was elected Lead Independent Director effective October 26, 2026.
The board fixed its size at seven directors, effective October 26, 2026.
Gladstone Capital Corporation said director Walter H. Wilkinson Jr. resigned from its Board of Directors effective immediately, after notifying the company on October 22, 2026. The Board elected George "Chip" Stelljes, III as Lead Independent Director to succeed him, effective October 26, 2026, and reduced the board to seven directors effective the same day. The filing is a board change and does not report any financial results.
Walter H. Wilkinson Jr. resigned from the Board effective immediately; he had served as a director since 2014 and as Lead Independent Director since 2024
George "Chip" Stelljes, III elected Lead Independent Director, effective October 26, 2026
Board fixed at seven directors, effective October 26, 2026
Rent the Runway completed its previously announced $15,000,000 rights offering on October 20, 2026. Subscribers bought 2,501,262 Class A shares for about $8.9 million, and an investor group bought the unsubscribed shares at $3.55 each for about $6.1 million, so the company issued new shares that increase the total number outstanding.
Rights offering completed October 20, 2026, with subscribers exercising rights for 2,501,262 Class A shares and gross proceeds of about $8.9 million
Investor Group (CHS US Investments LLC, Gateway Runway, LLC and S3 RR Aggregator, LLC) bought unsubscribed shares at $3.55 per share under a backstop agreement
On October 21, 2026, the company issued 1,724,089 Class A shares under the backstop commitment, for gross proceeds of about $6.1 million
Walter H. Wilkinson Jr. resigned from Gladstone Land's Board of Directors, effective immediately, after notifying the company on October 22, 2026. The board elected George "Chip" Stelljes, III as Lead Independent Director effective October 26, 2026, and reduced the board to seven directors on the same date. This is a board governance change, with no financial results or guidance included in the filing.
Walter H. Wilkinson Jr. resigned from the board effective immediately; he had served as a director since 2014 and as Lead Independent Director since 2024.
George "Chip" Stelljes, III was elected to succeed Wilkinson as Lead Independent Director, effective October 26, 2026.
The board fixed the number of directors at seven, effective October 26, 2026.
Gladstone Commercial said director and Lead Independent Director Walter H. Wilkinson Jr. resigned from the board, effective immediately, after notifying the company on October 22, 2026. The board elected George "Chip" Stelljes, III to succeed him as Lead Independent Director, effective October 26, 2026, and reduced the board to seven directors on the same date.
Walter H. Wilkinson Jr. resigned from the Board of Directors effective immediately; he had served as a director since 2014 and as Lead Independent Director since 2024.
George "Chip" Stelljes, III was elected Lead Independent Director, effective October 26, 2026.
The board fixed the number of directors at seven, effective October 26, 2026.
NETSCOUT SYSTEMS filed an 8-K disclosing that Chief Operating Officer Sanjay Munshi resigned from all positions with the company and its subsidiaries on October 22, 2026, effective immediately. The filing does not state a reason for the resignation or name a successor.
Sanjay Munshi, Chief Operating Officer, resigned on October 22, 2026
Resignation covers all positions with the company and its subsidiaries, effective immediately
The filing does not name a replacement or give a reason for the departure
Xtend AI Robotics said its Chief Operating Officer, Amir Ofri, will resign effective October 31, 2026, under a mutual termination agreement signed October 22. On October 24, four other executives agreed to amendments that reduce their salaries by 15% from December 1, 2026, until the Compensation Committee determines the share price has sufficiently improved or sufficient debt or equity financing has closed. For shareholders, the filing discloses a senior operating departure and pay changes tied to share price and financing conditions.
Amir Ofri's resignation as COO takes effect October 31, 2026; the termination agreement was signed October 22, 2026.
Ofri is entitled to a termination payment equal to three times his monthly salary, plus a one-time NIS 30,000 (about $9,636) in lieu of a vehicle allowance.
From December 1, 2026, salaries of A. Shapira, Horesh, Liani and M. Shapira are reduced 15%, restored after a Compensation Committee determination.
Mor Swiel received 570,000 RSUs vesting monthly over 36 months; RSUs of all five executives vest in full upon a change in control.
Host Hotels & Resorts, through its operating partnership Host LP, entered into a restated senior unsecured credit agreement on October 21, 2026, replacing facilities that were due in January 2027 and January 2028. The filing describes the new revolver and term loans as maturing in January 2031 and January 2032, with pricing tied to the company's debt rating and a leverage-based pricing adjustment, and covenants substantially the same as before.
Revolver of $1.5 billion replaced with a new revolver in the same committed amount, maturing January 15, 2031, with extension options
Two term loans of $500 million each refinanced: Term A-1 maturing January 15, 2031 and Term A-2 maturing January 15, 2032
As of October 21, 2026, $500 million was outstanding under each term loan and no revolver borrowings other than existing letters of credit
Financial covenants are substantially the same as the prior agreement, including a leverage ratio not exceeding 7.25:1.00
Greenbrier entered into a Cooperation Agreement with Atlas FRM LLC (d/b/a Atlas Holdings LLC) on October 24, 2026, and appointed Emanuel Pearlman as a director, effective October 27, 2026, increasing the board from ten to eleven members. Under the agreement, Mr. Pearlman will also serve on the Audit Committee and be nominated for election at the 2027 Annual Meeting, and he will resign from the board if Atlas proposes to acquire the company.
Board increased from ten to eleven directors; Mr. Pearlman appointed to Class III with a term expiring at the 2027 Annual Meeting
Mr. Pearlman will serve on the Audit Committee, effective October 27, 2026
Cooperation Agreement includes voting commitments, limited non-public information sharing, and standstill terms under Atlas's confidentiality agreement
Mr. Pearlman has irrevocably agreed to resign if Atlas or its affiliates announce a proposal to acquire all or a majority of voting securities or substantially all assets
BranchOut Food Inc. (Nasdaq: BOF) sold 2,941,177 new shares of common stock at $1.70 per share in an underwritten public offering that closed on October 26, 2026, with approximately $4.6 million in net proceeds. The company plans to use the proceeds for working capital and general corporate purposes, including operating expenses and capital expenditures. Issuing these new shares increases the number of shares outstanding, which dilutes existing shareholders' ownership.
Offering of 2,941,177 shares at $1.70 per share, with gross proceeds of about $5.0 million
Net proceeds of approximately $4.6 million after underwriting discounts, legal fees and offering expenses; closed October 26, 2026
Underwriter Lake Street Capital Markets LLC received a 30-day option to buy up to 441,176 additional shares
Underwriting discount of 7.0% on gross proceeds; officers and directors agreed to a 90-day lockup on share sales
Wrap Technologies increased its board from six to seven directors and appointed Edward Delatorre as a director effective immediately, with a term running to the 2026 annual meeting. The company also granted him options to buy 30,000 shares at $1.45 per share, a routine director compensation step that adds a small amount of potential dilution.
Board appointed Edward Delatorre on October 20, 2026; board expanded from six to seven directors
Delatorre has not yet been named to any board committee
Options cover 30,000 shares at an exercise price of $1.45 per share, with a ten-year term
50% of the options vest on October 20, 2027; the remainder vest in four equal quarterly installments over the following year
Crown Holdings, Inc. elected Wayne T. Smith to its Board of Directors effective October 21, 2026, and appointed him to the Audit Committee. The filing says the Board now has eleven members; the change is a board appointment with no financial results or guidance disclosed.
Wayne T. Smith elected to the Board effective October 21, 2026, and appointed to the Audit Committee
Smith was Chairman and CEO of BASF Corporation from 2015 to 2021 and currently chairs Air Products and Chemicals, Inc. and serves as a director of ONEOK, Inc.
Smith receives the same non-employee director compensation as other directors; no related-party arrangements are disclosed
On October 23, 2026, Churchill Capital Corp XIII appointed Paul Lapping to its board of directors and as chairperson of the audit committee, replacing William Sherman, who had served as interim chair. The company also agreed to pay each of Mr. Lapping and Mr. Sherman $75,000 per year in director cash compensation, starting October 1, 2026.
Paul Lapping appointed director and audit committee chair effective October 23, 2026, replacing interim chair William Sherman
Directors receive $75,000 per year in cash compensation, beginning October 1, 2026
Mr. Lapping signed a joinder to the July 30, 2026 letter agreement, waiving certain redemption rights and agreeing to vote in favor of an initial business combination
Willis Lease Finance Corporation announced it will release third quarter 2026 financial results before the market opens on November 3, 2026, and hold a conference call that day at 10:00 a.m. Eastern Time. The filing is a scheduling notice and contains no financial results, so it gives shareholders no new performance data yet.
Third quarter 2026 results to be released before market open on Tuesday, November 3, 2026
Conference call set for November 3, 2026 at 10:00 a.m. Eastern Time, led by executive management
Replay to be available two hours after the call on the company's website, www.wlfc.global
Landmark Bancorp's Board declared a $0.21 per share cash dividend and a 5% stock dividend. The cash dividend is payable November 27, 2026, to holders of record on November 12, 2026, and the stock dividend is issued December 16, 2026, to holders of record on December 2, 2026. The filing says this is the 26th consecutive year the company has declared a 5% stock dividend, which sets out the cash and stock payment schedule for shareholders.
Cash dividend of $0.21 per share, payable November 27, 2026, to holders of record as of November 12, 2026
5% stock dividend issued December 16, 2026, to holders of record as of December 2, 2026
Filing states this is the 26th consecutive year Landmark has declared a 5% stock dividend
UFP Industries amended its credit agreement, extending the maturity of its $750 million revolving credit facility to October 23, 2031. The company also agreed to acquire the operating assets of Apache Products, Inc. for approximately $27 million, with closing expected on or around November 16, 2026.
Fifth Amendment, effective October 23, 2026, extends the $750 million revolver to October 23, 2031.
As of September 26, 2026, no cash borrowings were outstanding and about $42 million of letters of credit were outstanding.
Apache Products, a Silsbee, Texas pallet maker, is being acquired for approximately $27 million and adds about $55 million in annual sales and 165 employees.
The acquisition is expected to close on or around November 16, 2026, subject to customary closing conditions.
XBiotech's board appointed Dr. Sushma Shivaswamy, who had been interim CEO since December 2025 and remains Chief Scientific Officer, and Jan-Paul Simard as co-chief executive officers effective October 23, 2026. Simard is the son of founder John Simard, and his employment agreement includes a one-time grant of 2,000,000 stock options, which shareholders may weigh alongside the leadership change.
Dr. Sushma Shivaswamy, 48, has been with XBiotech for 17 years and will continue as Chief Scientific Officer with an annual salary of $750,000.
Jan-Paul Simard, 24, joined in 2012; his Executive Employment Agreement is dated October 26, 2026, with a base salary of $150,000, prorated through the end of 2026.
Simard's initial grant is 2,000,000 stock options, exercisable over ten years and vesting over three years in six-month intervals.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.